Key result
miR-3908 significantly suppressed the migration and proliferation of MCF-7 breast cancer cells by directly targeting AdipoR1 and regulating its interaction with Flotillin-1 in lipid rafts.
Why the study?
Does miR-3908 regulate cell migration and proliferation in the human breast cancer cell line MCF-7?
Does miR-3908 regulate cell migration and proliferation in the human breast cancer cell line MCF-7?
p-value: p=<0.001
miR-3908 inhibits breast cancer cell migration by targeting AdipoR1 and regulating its interaction with Flotillin-1 in lipid rafts, suggesting a potential therapeutic target for breast cancer.
Premature for clinical biomarker use; leaves open miR-3908's mechanistic role pending in vivo validation.
BACKGROUND: The mechanisms of lipid raft regulation by microRNAs in breast cancer are not fully understood. This work focused on the evaluation and identification of miR-3908, which may be a potential biomarker related to the migration of breast cancer cells, and elucidates lipid-raft-regulating cell migration in breast cancer. METHODS: To confirm the prediction that miR-3908 is matched with AdipoR1, we used 3'-UTR luciferase activity of AdipoR1 to assess this. Then, human breast cancer cell line MCF-7 was cultured in the absence or presence of the mimics or inhibitors of miR-3908, after which the biological functions of MCF-7 cells were analyzed. The protein expression of AdipoR1, AMPK, and SIRT-1 were examined. The interaction between AdipoR1 and Flotillin-1, or its effects on lipid rafts on regulating cell migration of MCF-7, was also investigated. RESULTS: AdipoR1 is a direct target of miR-3908. miR-3908 suppresses the expression of AdipoR1 and its downstream pathway genes, including AMPK, p-AMPK, and SIRT-1. miR-3908 enhances the process of breast cancer cell clonogenicity. miR-3908 exerts its effects on the proliferation and migration of MCF-7 cells, which are mediated by lipid rafts regulating AdipoR1's ability to bind Flotillin-1. CONCLUSIONS: miR-3908 is a crucial mediator of the migration process in breast cancer cells. Lipid rafts regulate the interactions between AdipoR1 and Flotillin-1 and then the migration process associated with miR-3908 in MCF-7 cells. Our findings suggest that targeting miR-3908 and the lipid raft, may be a promising strategy for the treatment and prevention of breast cancer.
No takes yet. Share an insight, caveat, or question.
Li et al. (2017) studied Breast cancer. miR-3908 mimics and inhibitors vs. Negative control was evaluated on Cell migration and proliferation (p=<0.001). miR-3908 significantly suppressed the migration and proliferation of MCF-7 breast cancer cells by directly targeting AdipoR1 and regulating its interaction with Flotillin-1 in lipid rafts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: